Video Review: Talking Biopolitics – A conversation with Paul Knoepfler and Nathaniel Comfort
By Dr. Rebecca Dimond,
BioNews
| 02. 01. 2016
Untitled Document
On 26 January 2016, the Center for Genetics and Society hosted an online discussion on 'Exploring heritable genetic modification: the promise and perils of altering future humans'. Paul Knoepfler, author of the 2015 book 'GMO Sapiens: The Life-Changing Science of Designer Babies', was interviewed by science historian Nathaniel Comfort.
I was looking forward to this webinar. The discussion was timely, following the passing of legislation on mitochondrial donation in the UK in 2015, and amid current debates about gene-editing technologies, such as CRISPR. Introducing the conversation, Marcy Darnovsky told the audience that genetic modification is 'now with us', a thought she described as both lively and sobering. Knoepfler's views about these developments are well known – during the UK mitochondrial donation debates, he contributed evidence to the scientific reviews, was mentioned at the House of Commons and House of Lords and hosts his own popular blog. He recently tweeted that he was 'excited about genetic modification' but was also cautious about 'talk of clinic use'.
Much of the conversation focused on the risks and benefits of...
Related Articles
Artificial Intelligence (AI) has been a major focus of news recently, as it should have been, under the appropriately ridiculous name of Hugging Face, “a leading collaboration platform and community hub for machine learning, artificial intelligence, and data science.” In July, Hugging Face was hacked. The platform itself responded:
Earlier this week, we detected and responded to an intrusion into part of our production infrastructure. This one was different from anything we had handled before in one important way...
By Miryam Naddaf, Nature | 09.21.2026
A wave of epigenetic therapies is offering hope as ways to cure chronic hepatitis B — a lingering liver infection that is caused by the hepatitis B virus (HBV) and affects more than 250 million people around the world. Currently...
By Karen Weintraub, Endpoints News | 09.16.2026
To better understand certain neuropsychiatric disorders, researchers at Stanford University have bred rodents that lack a cortex and hippocampus and then replaced those missing brain cells with human ones.
The altered mice, a scientific first, provided insights that would not...
By Ryan Cross, Endpoints News | 09.02.2026
The deaths of two children who received CRISPR therapies in China have rattled scientists who work on similar genetic medicines in the US, adding new fuel to a yearslong debate about the danger of the gene therapy field’s most-used delivery...
